Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CyDex Pharmaceuticals Announces CAPTISOL® Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV
CyDex Pharmaceuticals Announces CAPTISOL® Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV
CyDex Pharmaceuticals Announces CAPTISOL® Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV
Submitted by
admin
on January 10, 2009 - 12:18pm
Source:
PR- Inside
News Tags:
CyDex Pharmaceuticals
NEXTERONE
Headline:
CyDex Pharmaceuticals Announces CAPTISOL® Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV
Do Not Allow Advertisers to Use My Personal information
